MNK News 86.00 09/15/2014 09:47:57 Mallinckrodt Plc Ordinary

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mallinckrodt Plc Ordinary Share (MNK) 86.00 $MNK

Can Mallinckrodt public limited (MNK) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 12, 7:54AM CDT
Mallinckrodt public limited could be a great candidate for another beat after a solid performance in the last two quarters.

Mylan to Acquire U.S. Rights to Arixtra for up to $300M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 11, 4:20PM CDT
Mylan (MYL) is all set to acquire the U.S. commercialization, marketing and intellectual property rights to Arixtra injection from Aspen.

Actavis' Bystolic Combination Gets Negative FDA Panel Vote - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 3:45PM CDT
Actavis plc (ACT) announced that the FDA's CRDAC has voted against the approval (in the ratio of 6:4) of Actavis' fixed-dose combination (FDC) of Bystolic (nebivolol) and Novartis' (NVS) Diovan (valsartan).

Emergent BioSolutions Wins $29M Anthrax Vaccine Deal - Analyst Blog
Maharathi Basu - Zacks Investment Research - Wed Sep 10, 3:30PM CDT
Emergent BioSolutions (EBS) secured a federal contract worth up to $29 million.

Endocyte (ECYT) Worth Watching: Stock Soars 17% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 8:46AM CDT
Endocyte (ECYT) was a big mover last session, with shares rising just over 17% on the day.

Actavis' Antibiotic under FDA Review, Response in 1Q15 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 4:20PM CDT
Actavis plc (ACT) announced the acceptance of its new drug application for its antibiotic candidate, ceftazidime-avibactam, by the FDA.

Mallinckrodt (MNK) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 9:39AM CDT
Mallinckrodt (MNK) Shares March Higher, Can It Continue?

Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma
PR Newswire - Mon Sep 08, 8:25AM CDT
On Friday, September 5, 2014, the NASDAQ Composite ended at 4,582.90, up 0.45%, the Dow Jones Industrial Average advanced 0.40%, to finish the day at 17,137.36, and the S&P 500 closed at 2,007.71, up 0.50%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 741.23, up 0.57%, with the index also advancing 6.70% in the last three months. Investor-Edge has initiated coverage on the following equities: Allergan Inc. (NYSE: AGN), Akorn Inc. (NASDAQ: AKRX), Mallinckrodt PLC (NYSE: MNK), Mylan Inc. (NASDAQ: MYL), and AVANIR Pharmaceuticals Inc. (NASDAQ: AVNR). Free research on these five companies can be accessed at:

IntelliPharmaCeutics (IPCI) in Focus: Stock Gains 15.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 8:25AM CDT
IntelliPharmaCeutics (IPCI) was a big mover last session, with shares rising nearly 16% on the day.

New Center, Clinical Study Results, Collaborations, and Upcoming Event - Research Reports on Centene, Mallinckrodt, Infinity, Celgene and UnitedHealth
PR Newswire - Mon Sep 08, 7:55AM CDT
Today, Analysts Review released its research reports regarding Centene Corp. (NYSE: CNC), Mallinckrodt PLC (NYSE: MNK), Infinity Pharmaceuticals Inc. (NASDAQ: INFI), Celgene Corporation (NASDAQ: CELG) and UnitedHealth Group Inc. (NYSE: UNH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6280-100free.

New REMS Education Program Helps Increase Safe, Responsible Use of Opioid Analgesics for Pain Relief
Business Wire - Mon Sep 08, 7:01AM CDT
Assessments of a novel Continuing Medical Education (CME) initiative showed meaningful changes in opioid prescribing behavior and improvements in pain-patient outcomes. These assessments of REMEDIES (Risk Evaluation and Mitigation Strategies - An Employer-Driven CME Initiative for Efficacy and Safety) - were presented this past week at PAINWeek, the nation's largest conference for clinicians with an interest in pain management.

Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 4:05PM CDT
Mallinckrodt plc (MNK) announced encouraging results from a phase III efficacy study on its pain candidate, MNK-155.

Mallinckrodt Pharmaceuticals Presents 11 Posters with Data on Investigational Opioid, MNK-155, and XARTEMIS(TM) XR (oxycodone hydrochloride and acetaminophen) Extended Release Tablets (CII) at PAINWeek 2014
Business Wire - Fri Sep 05, 8:00AM CDT
Mallinckrodt (NYSE: MNK) presented 11 posters with data on its investigational opioid, MNK-155, an extended-release oral formulation of hydrocodone and acetaminophen, and recently FDA-approved XARTEMIS XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII), at PAINWeek, September 2-6 in Las Vegas, Nevada. The studies examined the compound's efficacy, safety, abuse-related characteristics and release/delivery profiles with immediate- and extended-release components.

Actavis' Gastrointestinal Drug Under FDA Priority Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 3:30PM CDT
Shares of Actavis plc (ACT) were up 0.9% after the company announced that the FDA has granted priority review status to its New Drug Application (NDA) for its gastrointestinal candidate, eluxadoline.

Today's Momo Momentum Stock To Watch: Mallinckrodt (MNK)
at The Street - Thu Sep 04, 8:50AM CDT
Trade-Ideas LLC identified Mallinckrodt (MNK) as a momo momentum candidate

Tetraphase Pharmaceuticals (TTPH) in Focus: Stock Gains 14.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 8:46AM CDT
Tetraphase Pharmaceuticals (TTPH) was a big mover last session, with shares rising nearly 15% on the day.

10 Stocks Billionaire John Paulson Loves in 2014
at The Street - Thu Sep 04, 8:33AM CDT
Here's a look at 10 stocks that Paulson & Co. bought in the most recently reported quarter.

Mallinckrodt Pharmaceutical's MNK-155, an Extended-Release Hydrocodone/Acetaminophen Combination, Shows Efficacy in Phase 3 Acute Pain Trial
Business Wire - Thu Sep 04, 8:00AM CDT
Mallinckrodt (NYSE: MNK) today reported that a Phase 3 efficacy trial of investigational MNK-155 met the study's primary endpoint of improved pain scores vs. placebo over the first 48 hours following bunionectomy (p<0.001). This difference in pain scores was statistically significant in favor of MNK-155. The data is being presented at PAINWeek 2014, a national conference on pain for frontline practitioners, held in Las Vegas, Nevada September 2-6, 2014.

Merck KGaA in Deal with S-TARget, Allergy Pipeline in Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 5:50PM CDT
Merck KGaA's (MKGAF) Allergopharma, strikes deal with S-TARget therapeutics for developing a new generation of therapies for allergies using S-TIR technology.

Novo Nordisk Drops Anti-Inflammatory R&D Activities - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 5:20PM CDT
Novo Nordisk (NVO) intends to ramp up its efforts to strengthen its core business area - diabetes prevention and treatment, obesity and diabetes complications.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 0

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 0

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Investor Sentiment and Trends on SNAP Options

Updated Category News Views 251

Understanding Investor Sentiment and Trends on SNAP Options Investors are showing an intriguing trend towards Snap (NASDAQ: SNAP) as they engage in notable options trading activities, indicating a potential shift in market dynamics that shouldn't be overlooked. Our examination of public options records reveals that significant players are backing a more optimistic outlook...

Continue Reading
StarKist Partners with Kyle Busch Family for Exciting Season

Updated Category News Views 202

StarKist and the Busch Family Kick Off NASCAR 2026 As the exhilarating NASCAR season launches, StarKist Co. is excited to announce its partnership with NASCAR champion Kyle Busch, wellness advocate Samantha Busch, and young racer Brexton Busch. Building upon a successful initial year, this collaboration emphasizes the importance of healthy, ready-to-eat protein options...

Continue Reading
Teva's Upcoming Presentations at Leading Healthcare Conferences

Updated Category News Views 166

Teva's Upcoming Presentations at Major Investor Conferences In a significant announcement, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is set to showcase its commitment to healthcare innovation. Richard Francis, the esteemed President and CEO of Teva, will represent the company at two prestigious investor conferences this September. Morgan Stanley Global Healthcare...

Continue Reading
Earth Animal Celebrates the Holiday Season with Giving Back

Updated Category News Views 63

Earth Animal's Heartwarming Holiday Initiative This holiday season, Earth Animal has kicked off a touching initiative called "Buy Joy to Gift Joy," which aims to make a difference in the lives of shelter dogs. In collaboration with Greater Good Charities, for every Pumpkin Spice or Holiday Feast No-Hide Chew sold, the company will donate one No-Hide® Strip to a shelter...

Continue Reading
Elderly American Sentenced in Russia Amid Rising Tensions

Updated Category News Views 71

Understanding the Sentencing of Stephen Hubbard A Moscow court has sentenced Stephen Hubbard, a 72-year-old American citizen, to six years and 10 months in prison for alleged involvement in combat against Russian forces alongside a Ukrainian unit. This case marks a significant moment, as it is the first instance of an American receiving imprisonment on 'mercenary' grounds...

Continue Reading